Skip to content
Home/Companies/MedTech/Hemerion
Hemerion

Hemerion

MedTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Hemerion?

Hemerion is a French MedTech company, currently owned by Finorpa Gestion since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Finorpa Gestion
Investor
Finorpa Gestion
Captech Sante · 2022 · Life Sciences VC

Key facts

HQFrance
SectorMedTech
Websitehemerion.com

More from Captech Sante

Other portfolio companies in the same fund.

Genoskin
Genoskin
Active
BiotechFrance· 2024
Nutriearth
Nutriearth
Active
FoodTechFrance· 2024
Vaxinano
Vaxinano
Active
BiotechFrance· 2024
Verley
Verley
Active
FoodTechFrance· 2023
Lattice Medical
Lattice Medical
Active
MedTechFrance· 2022
Posos
Posos
Active
HealthTechFrance· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Hemerion?

Hemerion is currently owned by Finorpa Gestion, through Captech Sante, since 2022.

When did Finorpa Gestion acquire Hemerion?

Finorpa Gestion acquired Hemerion in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue